EU Life Sciences Strategy, comments to the call for evidence

The call for evidence closed on 17 April, and the proposal of the draft EU Life Sciences Strategy is expected by Q2 2025. It should encompass all the different industrial sectors in which life sciences play a central role for R&D and competitiveness, including pharmaceuticals, biotech and medtech

Academic patenting on the rise

by Giuliana Miglierini Patents represent a fundamental element supporting the improvement of the EU’s competitiveness in the global…